학술논문
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
Document Type
Article
Author
Source
In ESMO Open February 2022 7(1)
Subject
Language
ISSN
2059-7029